The Role of the IGF Axis in Epithelial-to-Mesenchymal Transition during the Progression of Prostate Cancer

作者: Rehanna Mansor , Amit Bahl , Jeffrey MP Holly , Claire Perks , None

DOI:

关键词: CancerVimentinCancer cellProstate cancerMesenchymal stem cellMedicineEpithelial–mesenchymal transitionInternal medicineMalignant transformationOncologyProstate

摘要: Prostate cancer is the second most common lethal in men worldwide. Despite fact that prognosis for patients with localized disease good, many succumb to metastatic development of resistance hormone treatments. This normally termed castration-resistant prostate (CRPC). The metastatic, has been associated epithelial-to-mesenchymal transition (EMT), a process where cells acquire more mesenchymal phenotype enhanced migratory potential, invasiveness and elevated apoptosis. main event EMT repression epithelial markers such as E-cadherin upregulation N-cadherin, vimentin fibronectin. insulin-like growth factor (IGF) signalling axis essential normal maintenance tissues, including prostate, dysregulation this pathway contributes progression malignant transformation. It becoming increasingly clear one ways which IGF impacts upon through promoting EMT. review will explore role specific focus on involvement its downstream pathways regulating cancer.

参考文章(131)
Shoji Natsugoe, Mitsuteru Natsuizaka, Seiji Naganuma, Hideaki Kinugasa, Sanders Chang, Devraj Basu, Harry Subramanian, Andres J Klein-Szanto, Phyllis A Gimotty, Yoshiaki Kita, Hiroshi Nakagawa, Naryan L Rustgi, Kelly A Whelan, Shingo Kagawa, J Alan Diehl, Kei J Nakagawa, IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment. American Journal of Cancer Research. ,vol. 4, pp. 29- 41 ,(2014)
William H. Daughaday, William D. Salmon, A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. Journal of Laboratory and Clinical Medicine. ,vol. 116, pp. 408- 419 ,(1957) , 10.5555/URI:PII:0022214357900914
Natasha Kyprianou, Campbell M. Grant, Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression Translational Andrology and Urology. ,vol. 2, pp. 202- 211 ,(2013) , 10.3978/J.ISSN.2223-4683.2013.09.04
Martin Jechlinger, Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. Journal of Mammary Gland Biology and Neoplasia. ,vol. 7, pp. 415- 432 ,(2002) , 10.1023/A:1024090116451
Chino S. Aneke-Nash, Christina M. Parrinello, Swapnil N. Rajpathak, Thomas E. Rohan, Elsa S. Strotmeyer, Stephen B. Kritchevsky, Bruce M. Psaty, Petra Bůžková, Jorge R. Kizer, Anne B. Newman, Howard D. Strickler, Robert C. Kaplan, Changes in Insulin‐Like Growth Factor‐I and Its Binding Proteins Are Associated with Diabetes Mellitus in Older Adults Journal of the American Geriatrics Society. ,vol. 63, pp. 902- 909 ,(2015) , 10.1111/JGS.13390
Rudolf Kaaks, Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Foundation symposium. ,vol. 262, pp. 247- 264 ,(2004) , 10.1002/0470869976.CH16
J A Galván, I Zlobec, M Wartenberg, A Lugli, B Gloor, A Perren, E Karamitopoulou, Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer. British Journal of Cancer. ,vol. 112, pp. 1944- 1950 ,(2015) , 10.1038/BJC.2015.177
Jeffrey M P Holly, Kalina Biernacka, Claire M Perks, Role of the IGF axis in prostate cancer. Minerva Endocrinologica. ,vol. 37, pp. 173- ,(2012)
Kevin Morrison, Michael Cox, Majid Akbari, Hideaki Miyake, Martin E Gleave, Duan Yu, Tobias Zellweger, Satoshi Kiyama, Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Cancer Research. ,vol. 63, pp. 3575- 3584 ,(2003)
Ashley M. Holder, Argun Akcakanat, Farrell Adkins, Kurt Evans, Huiqin Chen, Caimiao Wei, Denai R. Milton, Yisheng Li, Kim-Anh Do, Filip Janku, Funda Meric-Bernstam, Epithelial to mesenchymal transition is associated with rapamycin resistance Oncotarget. ,vol. 6, pp. 19500- 19513 ,(2015) , 10.18632/ONCOTARGET.3669